Lilly says Cialis is gaining on Viagra

Share this article:
Eli Lilly said Cialis is gaining market share from the top-selling erectile dysfunction (ED) drug, Pfizer’s Viagra. Cialis has gained more than 3% of global market share between July 2005 and July 2006, Lilly said during a presentation to analysts. Sales of Cialis continue to grow in most markets around the globe, including the US, Europe and Latin America. Cialis is on track to be the No. 1 ED drug worldwide -- excluding the US -- by next year, Lilly said. Viagra had 49.3% of the global market as of July, while Cialis had 35.5%, Lilly said. Third-place Levitra, made by GlaxoSmithKline, had about 15.3% of the market. Lilly did not make any claims for overtaking Viagra inside the US, where Viagra holds 58% of the market, compared with 25% for Cialis, Worldwide, Cialis sales are expected to top $1 billion in 2007, which would make it one of Lilly's top five drugs. Cialis is a top-selling ED drug in 17 countries, including France, where it is commonly referred to as "le weekender." Lilly will launch Cialis next year in Japan. Lilly is buying its Cialis marketing partner, Seattle-based Icos, for about $2.1 billion. Cialis' patent does not expire until 2017.
Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.